acetylcysteine has been researched along with Cognition Disorders in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 16 (72.73) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Kamińska, K; Lech, MA; Lorenc-Koci, E; Rogóż, Z | 1 |
| Chang, H; Jo, SA; Kim, BS; Kim, YI; Kwon, DH; Leem, YH | 1 |
| Baillie, GS; Boomkamp, SD; Tsakiris, S; Zarros, A | 1 |
| Abdel Baki, SG; Bergold, PJ; Dash, P; Ershova, A; Grill, RJ; Grin'kina, NM; Haber, M; Irizarry, R; Orsi, S | 1 |
| Kalra, JK; Kumar, A; Prakash, A | 1 |
| Baker, NL; Gray, KM; Roten, A | 1 |
| Berk, M; Byrne, LK; Dean, OM; Gray, LJ; Ives, K; Lane, SE; Lewis, M; Marriott, AJ; Osborne, C; Page, R; Skvarc, DR; Stupart, D; Turner, A | 1 |
| Chopra, K; Kamboj, SS; Sandhir, R | 1 |
| Abel, T; Bizily, SF; Esposito, MF; Favilla, C; Kanes, SJ; Kelly, MP; Stein, JM; Vecsey, CG; Wand, G; Yang, X | 1 |
| Kumar, A; Prakash, A | 1 |
| Hudson, PR; McCaddon, A | 1 |
| Cummings, JL | 1 |
| Aluise, CD; Butterfield, DA; Huang, Q; Joshi, G; Markesbery, WR; St Clair, DK; Sultana, R | 1 |
| Jain, S; Kumar, CH; Mediratta, PK; Suranagi, UD | 1 |
| Albayram, O; Beck, H; Bilkei-Gorzó, A; Drews, E; Filiou, MD; Frisch, P; Guerrero, C; Kudin, A; Kunz, WS; Otte, DM; Sommersberg, B; Turck, CW; Yilmaz, O; Zimmer, A | 1 |
| Chen, SH; Gean, PW; Hsiao, YH; Kuo, JR | 1 |
| Barichello, T; Comim, CM; Dal-Pizzol, F; Generoso, JS; Michelon, CM; Mina, F; Otaran, P; Quevedo, J; Santos, AL; Savi, GD; Steckert, AV | 1 |
| Cao, L; Li, L; Zuo, Z | 1 |
| Dhanda, S; Kaur, S; Sandhir, R | 1 |
| Balaban, C; Hoffer, B; Hoffer, ME; Slade, MD; Tsao, JW | 1 |
| McCaddon, A | 1 |
1 review(s) available for acetylcysteine and Cognition Disorders
| Article | Year |
|---|---|
L-methylfolate, methylcobalamin, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline.
Topics: Acetylcysteine; Alzheimer Disease; Cognition Disorders; Free Radical Scavengers; Homocysteine; Humans; Oxidative Stress; Plaque, Amyloid; Tetrahydrofolates; Vitamin B 12; Vitamin B Complex | 2010 |
3 trial(s) available for acetylcysteine and Cognition Disorders
| Article | Year |
|---|---|
Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence.
Topics: Acetylcysteine; Adolescent; Cannabinoids; Cognition; Cognition Disorders; Combined Modality Therapy; Counseling; Female; Free Radical Scavengers; Humans; Male; Marijuana Abuse; Memory; Memory Disorders; Neuropsychological Tests; Psychomotor Performance; Time Factors; Treatment Outcome; Young Adult | 2015 |
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Clinical Protocols; Cognition; Cognition Disorders; Double-Blind Method; Drug Administration Schedule; Female; Hospitals, University; Humans; Inflammation Mediators; Male; Middle Aged; Neuropsychological Tests; Oxidative Stress; Research Design; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Victoria | 2016 |
Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study.
Topics: Acetylcysteine; Adolescent; Adult; Blast Injuries; Brain Injuries; Cognition Disorders; Double-Blind Method; Female; Free Radical Scavengers; Humans; Iraq War, 2003-2011; Male; Memory Disorders; Military Personnel; Neuropsychological Tests; Placebos; Severity of Illness Index; Sleep Initiation and Maintenance Disorders | 2013 |
18 other study(ies) available for acetylcysteine and Cognition Disorders
| Article | Year |
|---|---|
N-Acetylcysteine and Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF Levels in a Rat Model of Schizophrenia.
Topics: Acetylcysteine; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition; Cognition Disorders; Disease Models, Animal; Female; Hippocampus; Prefrontal Cortex; Pregnancy; Quinolones; Rats; Rats, Sprague-Dawley; Schizophrenia; Social Behavior | 2022 |
Exercise ameliorates cognition impairment due to restraint stress-induced oxidative insult and reduced BDNF level.
Topics: Acetylcysteine; Aldehydes; Animals; Brain-Derived Neurotrophic Factor; Cognition; Cognition Disorders; Corticosterone; Dose-Response Relationship, Drug; Exercise Test; Hippocampus; Hydrogen Peroxide; Immunohistochemistry; Male; Malondialdehyde; Maze Learning; Mice; Mice, Inbred C57BL; Oxidative Stress; Phosphorylation; Physical Conditioning, Animal; Primary Cell Culture; Reactive Oxygen Species; Restraint, Physical; Signal Transduction; Stress, Psychological | 2013 |
The extent and the nature of the cholinergic contribution to the hepatic encephalopathy-induced cognitive impairment.
Topics: Acetylcysteine; Animals; Bile Ducts; Cognition Disorders; Hepatic Encephalopathy; Male; Oxidative Stress | 2013 |
Minocycline plus N-acetylcysteine synergize to modulate inflammation and prevent cognitive and memory deficits in a rat model of mild traumatic brain injury.
Topics: Acetylcysteine; Animals; Avoidance Learning; Brain Injuries; Cognition Disorders; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Inflammation; Memory Disorders; Minocycline; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2013 |
Neuroprotective effect of N-acetyl cysteine against streptozotocin-induced memory dysfunction and oxidative damage in rats.
Topics: Acetylcysteine; Animals; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Maze Learning; Memory Disorders; Mitochondria; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Streptozocin | 2015 |
Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes.
Topics: Acetylcholinesterase; Acetylcysteine; Animals; Brain; Brain Diseases; Cognition Disorders; Diabetes Mellitus, Experimental; Hyperglycemia; Lipid Peroxidation; Male; Maze Learning; Neuroprotective Agents; Oxidative Stress; Random Allocation; Rats; Rats, Wistar | 2008 |
Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia.
Topics: Acetylcysteine; Acoustic Stimulation; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Behavior, Animal; Brain; Cognition Disorders; Conditioning, Psychological; Cyclic AMP; Disease Models, Animal; Erythromycin; Exploratory Behavior; Fear; Female; Gene Expression Regulation, Developmental; GTP-Binding Protein alpha Subunits, Gs; Haloperidol; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphodiesterase Inhibitors; Psychophysics; Reflex, Startle; Rolipram; Time Factors | 2009 |
Fighting the fog of "chemo brain." Chemotherapy may keep your cancer at bay but it also may cloud your mind.
Topics: Acetylcysteine; Activities of Daily Living; Adaptation, Psychological; Animals; Antineoplastic Agents; Attention; Cognition; Cognition Disorders; Humans; Memory; Risk Factors | 2009 |
Effect of N-acetyl cysteine against aluminium-induced cognitive dysfunction and oxidative damage in rats.
Topics: Acetylcholinesterase; Acetylcysteine; Aluminum Chloride; Aluminum Compounds; Animals; Brain; Catalase; Chlorides; Cognition Disorders; Glutathione; Lipid Peroxidation; Male; Maze Learning; Memory; Motor Activity; Oxidative Stress; Rats; Rats, Wistar | 2009 |
Commentary on: L-methylfolate, methylcobolamine, and N-acetylcysteine in the treatment of Alzheimer's disease-related cognitive decline.
Topics: Acetylcysteine; Alzheimer Disease; Cognition Disorders; Free Radical Scavengers; Humans; Tetrahydrofolates; Vitamin B 12 | 2010 |
Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment.
Topics: Acetylcysteine; Administration, Oral; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cognition Disorders; Disease Models, Animal; Drug Administration Schedule; Gene Knock-In Techniques; Humans; Male; Mice; Mice, Transgenic; Mutation; Oxidative Stress; Presenilin-1; Time Factors | 2010 |
Protective effect of N-acetylcysteine on bisphenol A-induced cognitive dysfunction and oxidative stress in rats.
Topics: Acetylcysteine; Animals; Antioxidants; Avoidance Learning; Benzhydryl Compounds; Brain; Cognition Disorders; Disease Models, Animal; Drug Antagonism; Glutathione; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Memory; Oxidative Stress; Phenols; Rats; Rats, Wistar; Space Perception | 2011 |
N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice.
Topics: Acetylcysteine; Animals; Carrier Proteins; Cognition Disorders; Electron Transport Complex I; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Transgenic; Mitochondrial Diseases; Reactive Oxygen Species; Treatment Outcome | 2011 |
Amelioration of social isolation-triggered onset of early Alzheimer's disease-related cognitive deficit by N-acetylcysteine in a transgenic mouse model.
Topics: Acetylcysteine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Antioxidants; Biophysics; Biotinylation; Calpain; Cell Line, Transformed; Cognition Disorders; Conditioning, Psychological; Cyclin-Dependent Kinase 5; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme-Linked Immunosorbent Assay; Fear; Hippocampus; Humans; In Vitro Techniques; Long-Term Potentiation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Patch-Clamp Techniques; Peptide Fragments; Presenilin-1; Protein Kinase C-delta; Receptors, Metabotropic Glutamate; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Social Isolation; Time Factors; Transfection | 2012 |
Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats.
Topics: Acetylcysteine; Animals; Antioxidants; Avoidance Learning; Behavior, Animal; Cerebral Cortex; Cognition Disorders; Deferoxamine; Free Radical Scavengers; Habituation, Psychophysiologic; Hippocampus; Lipid Peroxidation; Male; Memory; Meningitis, Pneumococcal; Oxidative Stress; Rats; Rats, Wistar; Survivors; Thiobarbituric Acid Reactive Substances | 2012 |
N-acetylcysteine reverses existing cognitive impairment and increased oxidative stress in glutamate transporter type 3 deficient mice.
Topics: Acetylcysteine; Aging; Animals; Antioxidants; Behavior, Animal; Brain; Cognition Disorders; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Transporter 3; Glutathione; Male; Mice; Mice, Knockout; Oxidative Stress | 2012 |
Preventive effect of N-acetyl-L-cysteine on oxidative stress and cognitive impairment in hepatic encephalopathy following bile duct ligation.
Topics: Acetylcysteine; Animals; Bile Ducts; Cognition Disorders; Hepatic Encephalopathy; Male; Oxidative Stress; Rats; Rats, Wistar | 2013 |
Homocysteine and cognitive impairment; a case series in a General Practice setting.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Antioxidants; Cognition Disorders; Family Practice; Female; Folic Acid; Humans; Hyperhomocysteinemia; Male; Memory Disorders; Memory, Short-Term; Radiography; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B Complex | 2006 |